Intended for healthcare professionals


Calcium channel blockers associated with less diabetes

BMJ 2006; 333 doi: (Published 07 September 2006) Cite this as: BMJ 2006;333:514
  1. Susan Mayor
  1. Barcelona

    Patients taking a treatment for high blood pressure based on a calcium channel blocker had a 34% lower risk of developing diabetes than patients using a β blocker. This result is from a substudy of the Anglo-Scandinavian cardiac outcomes trial (ASCOT) reported this week at the World Congress of Cardiology meeting in Barcelona.

    Treating patients with amlodipine, with or without the angiotensin converting enzyme inhibitor perindopril, was associated with a 34% reduction in new onset diabetes compared …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription